container

footer-social-menu

Sign Up for Emails

CONNECT WITH GALE

Stay up-to-date with the latest Gale news, exclusive offers, and more.

facebook

linkedin

instagram

youtube

SOCIAL ICONS

header-component

single-column

header

footer-legal-menu-component

products

footer-legal-menu

Terms of use

Privacy

Marketing materials, training documents, discovery services

cengage:card

FIND YOUR SALES REPRESENTATIVE

cengage:column

Get marketing materials, training documents, discovery services.

PRODUCT SUPPORT

CUSTOMER SUPPORT

Report technical issues, errors, check system status

TECHNICAL SUPPORT

Manage product preferences, generate usage reports, simplify administrative tasks.

ADMIN TOOLS

support

secondary-account-menu

config

cengage:galethorndikeseo

Profile

Orders

Wish List

Fast Order Entry

My Account

footer-menu-component

footer-menu

Academic Institutions

K-12

Public Libraries

Government and Special Libraries

Statewide Programs

Institutions

Databases

Primary Sources

Digital Humanities Tools

eLearning

Schools/K-12 Curriculum

Books

Large Print Books by Thorndike Press

Products

Find Your Rep

Product Support

Technical Support

Customer Support

Admin Tools

Accessibility Policy

Support

About Us

Blogs

Press Center

Events

News

Careers

Partnerships

Contact Us

Our Company

secondary-primary-menu

zone1

gale-footer

mega-menu

footer

secondary-storefront-menu

Browse by Institution Type

Browse by Product Type

FIND YOUR REP

support-order-2

zone2

zone3

Account Information

bundle-connector

Request a Trial

You may already have access to Gale content through your institution.

STUDENTS AND RESEARCHERS

support-order-1

footer-social-menu-component

%1 products have been added to your cart but %2 have been backordered and will be fulfilled when stock is available

Product on backorder

Current quantity limit is [maxProductQuantity], please, navigate to the cart page and change quantity of product

You will be able to resubmit promo in ${countdown} seconds. test

Please note that the taxes displayed on our website are estimated and subject to adjustment. The actual tax charges will be determined and settled during the final invoicing of your order

product-detail-component

Would you like to go to the Gale {{RECOMMENDED_COUNTRY}} site instead?

It looks like you're visiting from {{DETECTED_COUNTRY}}.

main

International

North America

China

Japan

Latin America

Brazil

Region

Set your region:

Global Clinical Trials for Alzheimer's Disease

GLOBAL CLINICAL TRIALS FOR ALZHEIMER'S DISEASE

Diseases & Conditions

Health, Medicine & Nursing

Gt Product Group

Binding Format

Marketing Imprint Name

B2B GT

CL Carton Count

Imprint Name

B2B & B2C

Global Clinical Trials for Alzheimer's Disease is a handy one-stop reference for researchers and physicians planning and conducting global clinical trials in this area. This book addresses important considerations that may arise during the successful design and execution of these trials, including site selection, local regulatory issues, pharmacogenomics, ethical matters and much more. Given the saturation of traditional clinical trial markets and the worldwide progression of Alzheimer's disease, there is a need to focus on clinical trials in emerging markets and developing countries. This book provides you with a practical approach to recognizing the opportunities and tackling the challenges that are present during the planning and execution of global clinical trials for Alzheimer's disease.

POST SECONDARY FOUR YEAR

COLFR

COLJR

COLSO

COLSR

Duration

Duration Unit Of Measure

Transaction Type

Front Cover.
Title Page.
Copyright Page.
International Editorial Advisors.
Contents.
Preface.
About the Editors.
List of Contributors.
Dedication.
1: Alzheimer&#x0027;s Disease: The Twenty-First Century Epidemic.
2: The Epidemiology and Prevention of Alzheimer&#x0027;s Disease and Projected Burden of Disease.
3: Developing a National Plan to Address Alzheimer&#x0027;s Disease.
4: Preventing Alzheimer&#x0027;s Disease.
5: Global Alzheimer&#x0027;s Disease: Clinical Trials.
6: Overview of Global Clinical Trials: Drivers/Issues/Opportunities of Globalization.
7: Challenges and Opportunities to Conduct Global Alzheimer&#x0027;s Disease Clinical Trials.
8: Challenges and Opportunities to Conduct Global Alzheimer&#x0027;s Disease Clinical Trials.
9: Lessons Learned from Major Clinical Trials Conducted Over the Past Decades.
10: Why the Negative Studies in Alzheimer&#x0027;s Disease?.
11: Global Regulatory Environment Surrounding Alzheimer&#x0027;s Disease Trials.
12: The Regulatory Environment Surrounding Alzheimer&#x0027;s Disease Research: FDA and EMA Guidance.
13: Standardization of Diagnostic and Outcome Measures in Global Alzheimer&#x0027;s Disease Trials.
14: Standardization of MRI and Amyloid Imaging.
15: Operationalization of Global Alzheimer&#x0027;s Disease Trials.
16: Operationalization of Global Alzheimer&#x0027;s Disease Trials.
17: Alzheimer&#x0027;s Disease Mortality and Patient Retention in Clinical Trials.
18: Minimizing Trial Costs by Accelerating and Improving Enrollment and Retention.
19: Enhancing Low and Middle Income Countries&#x0027; Capacity and Capability to Conduct Alzheimer&#x0027;s Disease Trials.
20: South America&#x0027;s AD Clinical Trials Experience:Lessons Learned from Argentina and Brazil.
21: Dementia Clinical Research in India.
22: Alzheimer&#x0027;s Disease Clinical Trials in China.
23: Lessons Learned: Alzheimer&#x0027;s Disease Clinical Trials in Eastern Europe.
24: Experience in Alzheimer&#x0027;s Disease Clinical Trials in Turkey.
25: Strengthening/Building Alzheimer&#x0027;s Disease Global Clinical Trial Site Capabilities and Capacity in and for Emerging Markets. Lessons Learned from Japan.
26: Strengthening/Building Alzheimer&#x0027;s Disease Global Clinical Trial Site Capabilities and Capacity in and for Developing/Emerging Markets. Lessons Learned from Korea&#x2020;.
27: Pharmacogenetics and Pharmacogenomics Considerations.
28: Pharmacogenomics in Developing Countries: Challenges and Opportunities.
29: Application of Pharmacogenomics in Global Alzheimer&#x0027;s Disease Clinical Trials and Ethical Implications.
30: Human Resources Planning.
31: Long-Term Human Resources Planning for Alzheimer&#x0027;s Disease Trials.
Index.

Global Clinical Trials for Alzheimer's Disease.css-1p8rvzy{position:absolute;padding-left:8px;}

Global Clinical Trials for Alzheimer's Disease